Psagot Value Holdings’s EnteroMedics Inc. ETRM Stock Holding History

Psagot Value Holdings’s Portfolio ETRM Stock Details ETRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-143	Closed	–	–	408
2016 Q4	$0	Buy	+143	New	+$750	﹤0.01%	427

Other funds holding ETRM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

EPM

Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Psagot Value Holdings's ETRM Position: Q1 2017 in Review

Psagot Value Holdings sold out of EnteroMedics Inc. (ETRM) in Q1 2017, closing a stake of 143 shares.

Psagot Value Holdings first reported a position in ETRM in Q4 2016 and held it in 1 quarter. The position peaked at $0 in Q4 2016. 26 funds tracked by Wall St. Rank hold ETRM as of Q1 2017.

Psagot Value Holdings reported no remaining EnteroMedics Inc. position as of Q1 2017 after selling out during the quarter.
Psagot Value Holdings sold 143 EnteroMedics Inc. shares in Q1 2017.
Psagot Value Holdings first reported a position in EnteroMedics Inc. in Q4 2016 and held it in 1 quarter.
Psagot Value Holdings's EnteroMedics Inc. position peaked at $0 in Q4 2016.
26 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q1 2017.

Based on Psagot Value Holdings's 13F filing for Q1 2017, filed 15 May 2017.